What to expect from immunotherapy for bladder cancer

Depending on the stage and previous treatment, immunotherapy may be given through a vein or placed into the bladder. Intravenous treatment is delivered in an infusion unit; bladder treatment uses a catheter and is followed by instructions for urination and hygiene. Your team checks symptoms, blood tests, and bladder or scan findings before deciding whether to continue.

Common effects can include tiredness, skin rash or itching, reduced appetite, nausea, feverishness, and changes in bowel habit. Because the treatment activates immune cells, inflammation can affect organs such as the thyroid, lungs, liver, kidneys, or bowel, sometimes after treatment has finished.

Keep every treatment and blood-test appointment, drink according to your team’s advice, and maintain a written list of medicines and symptoms. Tell clinicians about autoimmune disease, organ problems, transplant history, steroids, or other immune medicines. Do not start supplements or stop prescribed medicines without checking.

For bladder treatment, follow the clinic’s catheter, handwashing, laundry, and toilet instructions carefully. Pace activity around fatigue and report symptoms early; immune-related problems often need treatment before they become severe.

Contact your oncology team promptly for new diarrhoea, persistent vomiting, yellow skin, dark urine, severe rash, unusual bleeding, worsening cough, breathlessness, confusion, or much less urine. Seek urgent help for severe breathing difficulty, chest pain, collapse, or sudden weakness. Tell any emergency clinician that you are receiving immunotherapy.

Ask whether treatment is intravenous or bladder-based, how long each visit takes, which tests are needed, and how response will be assessed. Ask which symptoms require a same-day call, whether you should carry an immunotherapy alert card, and what happens if a dose is delayed.